News about "Active Pharmaceutical Ingredients "

SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development

SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development

Scientists at Southwest Research Institute have accidently made a discovery of an ion-assisted chromatography process to accelerate drug development.

Active Pharmaceutical Ingredients | 28/08/2025 | By Dineshwori

NATCO Launches Tracleer Generic in US with Lupin

NATCO Launches Tracleer Generic in US with Lupin

NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.

Active Pharmaceutical Ingredients | 20/08/2025 | By Dineshwori 105

Veranova Names Thomas Rohrer as Vice President of Bioconjugation

Veranova Names Thomas Rohrer as Vice President of Bioconjugation

Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Thomas Rohrer as Vice President of Bioconjugation.

Active Pharmaceutical Ingredients | 29/07/2025 | By Dineshwori

Medicines UK Hails India-UK Trade Deal, Calls for Clear Regulatory Pathway

Medicines UK Hails India-UK Trade Deal, Calls for Clear Regulatory Pathway

Medicines UK has called for the establishment of a clear regulatory framework to fully unlock the benefits of the newly signed Comprehensive Economic and Trade Agreement (CETA) between India and the UK.

Active Pharmaceutical Ingredients | 25/07/2025 | By Dineshwori

India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients

India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients

A total of 48 projects have been approved under the Production Linked Incentive (PLI) Scheme to boost domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) in India, according to the Ministry of Chemicals and Fertilizers.

Active Pharmaceutical Ingredients | 23/07/2025 | By Dineshwori 159

Dr. Reddy's Srikakulam Facility Gets Form 483 After USFDA Inspection

Dr. Reddy's Srikakulam Facility Gets Form 483 After USFDA Inspection

Dr. Reddy’s Laboratories has received a Form 483 with seven observations from the United States Food and Drug Administration (USFDA) following an inspection at its formulations manufacturing facility in Srikakulam, Andhra Pradesh.

Active Pharmaceutical Ingredients | 19/07/2025 | By Dineshwori 193

Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity

Amphastar to Expand US Manufacturing Footprint, Quadruple Production Capacity

Amphastar Pharmaceuticals aims to quadruple its production capacity at its headquarters in Rancho Cucamonga, California over the next three to five years.

Active Pharmaceutical Ingredients | 16/07/2025 | By Dineshwori

Global API Market Expected to Reach USD 422.8 Billion by 2034

Global API Market Expected to Reach USD 422.8 Billion by 2034

The global Active Pharmaceutical Ingredients (API) market is projected to grow at a compound annual growth rate (CAGR) of 6.7 percent to an estimated USD 422.8 billion by 2034, according to a report.

Active Pharmaceutical Ingredients | 09/07/2025 | By Dineshwori

Deadline for Submitting PLI Applications For KSM, API Manufacturing Extended Again

Deadline for Submitting PLI Applications For KSM, API Manufacturing Extended Again

The Department of Pharmaceuticals (DoP) has once again extended the deadline for submitting applications for the eligible products under the "Production Linked Incentive Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.”

Active Pharmaceutical Ingredients | 09/07/2025 | By Dineshwori 258

Nectar to Sell API, Formulations and Menthol Units to Ceph for INR 1,290 Cr

Nectar to Sell API, Formulations and Menthol Units to Ceph for INR 1,290 Cr

Nectar Lifesciences Ltd. is selling its core business division for INR 1,270 crore and its menthol business for INR 20 crore to Ceph Lifesciences.

Active Pharmaceutical Ingredients | 09/07/2025 | By Dineshwori 196


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members